|
Delayed
Nasdaq
16:00:00 2026-08-31 EDT
|
5-day change | 1st Jan Change | ||
| 84.95 USD | +0.13% |
|
-.--% | +82.49% |
| Market Cap | 9.01B 7.75B 7.31B 6.66B 12.45B 861B 12.56B 87.07B 33.51B 437B 33.84B 33.1B 1,388B | P/E 2026 * |
-18.5x | P/E 2027 * | -20.6x |
|---|---|---|---|---|---|
| Enterprise Value | 8B 6.88B 6.5B 5.92B 11.06B 765B 11.16B 77.36B 29.77B 388B 30.06B 29.4B 1,233B | EV / Sales 2026 * |
49.5x | EV / Sales 2027 * | 46.6x |
| Free-Float |
-
| Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CRNX | Delayed | |
CBOE
| CRNX | Real-time | |
|
Tradegate
| 6Z4 | Real-time | |
|
Deutsche Boerse AG
| 6Z4 | Delayed | |
|
Börse Stuttgart
| 6Z4 | Delayed |
Last Transcript : Crinetics Pharmaceuticals
| 1 day | +0.13% | ||
| 1 month | +1.03% | ||
| 3 months | +142.92% | ||
| 6 months | +122.27% | ||
| Current year | +82.49% |
| 1 month | 84.2 |  | 85.01 |
| Current year | 32.3 | | 85.01 |
| 1 year | 32.3 | | 85.01 |
| 3 years | 24.1 | | 85.01 |
| 5 years | 15.23 | | 85.01 |
| 10 years | 10.63 | | 85.01 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charles Wagner
PSD | President | 57 | 2026-08-31 |
Omar White
SEC | Corporate Secretary | - | 2026-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Charles Wagner
BRD | Director/Board Member | 57 | 2026-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/1/26 | Issuer sale | Chief Financial Officer | -209,427 | 0.1986% | ||
| 9/1/26 | Issuer sale | Founder | -905,240 | 0.8585% | ||
| 9/1/26 | Issuer sale | Chairman | -232,151 | 0.2202% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 162M 139M 131M 120M 224M 15.47B 226M 1.56B 602M 7.85B 608M 595M 24.93B | 180M 154M 146M 133M 248M 17.17B 250M 1.74B 668M 8.71B 674M 660M 27.66B |
| Net income | -447M -385M -363M -331M -618M -42.76B -624M -4.32B -1.66B -21.69B -1.68B -1.64B -68.89B | -470M -404M -382M -348M -650M -44.97B -656M -4.55B -1.75B -22.81B -1.77B -1.73B -72.44B |
| Net Debt | -1.01B -865M -816M -743M -1.39B -96.12B -1.4B -9.72B -3.74B -48.76B -3.78B -3.69B -155B | -647M -556M -525M -478M -894M -61.86B -902M -6.25B -2.41B -31.38B -2.43B -2.38B -99.66B |
| Date | Price | Change | Volume |
|---|
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- CRNX Stock
Select your edition
All financial news and data tailored to specific country editions
